Drug Profile
Research programme: glucagon and glucagon-like peptide-1 agonists - Arecor
Alternative Names: Aqueous Liraglutide - Arecor; Liraglutide - Arecor; Stable aqueous glucagon - ArecorLatest Information Update: 28 Oct 2020
Price :
$50
*
At a glance
- Originator Arecor
- Class Antihypoglycaemics; Glucagon-like peptides; Peptide hormones; Peptides
- Mechanism of Action Glucagon like peptide 1 receptor agonists; Glucagon receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 28 Oct 2020 No recent reports of development identified for preclinical development in Diabetes-mellitus in United Kingdom (Parenteral, Liquid)
- 15 Sep 2016 Preclinical trials in Diabetes mellitus in United Kingdom (Parenteral) before September 2016 (Arecor pipeline, September 2016)
- 15 Sep 2016 Arecor has patent protection for aqueous glucagon in (Arecor pipeline, September 2016)